Voltage-gated Ca~v~1.3 (L-type) Ca^2+^ channels mediate Ca^2+^ influx and exocytosis at the inner hair cell (IHC) synapse and are required for hearing^[@R1],[@R2]^. The C-terminus of the Ca~v~1.3 α~1~ subunit (α~1~1.3) binds to PDZ ([P]{.ul}SD-95 (Postsynaptic density-95)/[D]{.ul}iscs large/[Z]{.ul}O-1 (Zona occludens-1) domains, which affect neuronal Ca~v~1.3 localization and function^[@R3]^. In screening for PDZ-proteins that interact with Ca~v~1 α~1~-subunits, we discovered that harmonin (variant *a*), a PDZ-protein expressed in IHCs^[@R4]^, binds to α~1~1.3 via the second of its three PDZ domains ([Fig. 1a,b](#F1){ref-type="fig"}).

Like the PDZ-protein erbin^[@R5]^, harmonin promoted voltage-dependent facilitation of Ca~v~1.3 in transfected HEK293T cells (not shown). However, harmonin also significantly suppressed peak Ca~v~1.3 Ba^2+^ current (I~Ba~) density (\~66%, p\<0.001; [Fig. 1c](#F1){ref-type="fig"}) without major effects on voltage-dependent activation ([Supplementary table 1](#SD1){ref-type="supplementary-material"}). Harmonin significantly decreased maximal "on" gating charge (*Q*~on~) of I~Ba~ and tail current amplitudes at the reversal potential ([Fig. 1d](#F1){ref-type="fig"}, [Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}), which suggests that harmonin reduces the number of available Ca~v~1.3 channels rather than the open probability. Disrupting the type I PDZ binding sequence of α~1~1.3 by substituting the C-terminal leucine for alanine (L-A) prevented harmonin binding ([Fig. 1e](#F1){ref-type="fig"}) and inhibition of Ca~v~1.3 peak current density (p=0.93; [Fig. 1f](#F1){ref-type="fig"}).

As described previously ^[@R6]-[@R8]^, harmonin is strongly localized in the apical hair bundles of IHCs ([Supplementary Fig.2](#SD1){ref-type="supplementary-material"}). However, closer scrutiny revealed harmonin clusters at the base of IHCs, which colocalized with the ribbon synapse protein ribeye/CtBP2 at a subset of synapses ([Fig. 1g](#F1){ref-type="fig"}). Comparisons before (P6--8) and after (P14--16) hearing onset revealed a developmental increase in the number of harmonin-positive IHC synapses ([Fig. 1g](#F1){ref-type="fig"}). In most immature IHCs (30 of 35), harmonin was localized at \~10--30% of synapses per IHC. However, in mature IHCs (18 of 31), \~40--60% of synapses per IHC were harmonin-positive ([Fig. 1g](#F1){ref-type="fig"}). Ca~v~1.3 channels may be necessary for the synaptic localization of harmonin: the fraction of harmonin-positive synapses was significantly reduced in IHCs from *Ca~v~1.3*^−/−^ mice (\~26% of harmonin-positive synapses in WT, P6-8, n=84 IHCs, vs. \~10% in *Ca~v~1.3*^−/−^, P6-8, n=82 IHCs, p\<0.001; [Fig. 1g](#F1){ref-type="fig"}). Harmonin also coimmunoprecipitated with Ca~v~1.3 from cochlear extracts ([Supplementary Fig. 2](#SD1){ref-type="supplementary-material"}). These findings support a presynaptic association of harmonin with Ca~v~1.3, primarily in mature IHCs.

To determine if harmonin regulates presynaptic Ca~v~1.3 channels in IHCs, we analyzed "deaf-circler" mice (*dfcr*)^[@R9]^. While the mutant (*dfcr* harmonin) retains PDZ2 that interacts with α~1~1.3 ([Fig. 1b](#F1){ref-type="fig"}), an internal deletion removes the coiled-coil domain and causes abnormal proximity of the PDZ domains. *Dfcr* harmonin did not bind to α~1~1.3 ([Fig. 2a](#F2){ref-type="fig"}) or affect peak Ca~v~1.3 I~Ba~ density in transfected HEK293T cells (p=0.10; [Fig. 2b](#F2){ref-type="fig"}), which demonstrates that *dfcr* harmonin does not functionally interact with α~1~1.3. In agreement with a normally inhibitory role for harmonin, whole cell I~Ba~ density was greater in P16--18 *dfcr* IHCs than in control IHCs (\~33%, p\<0.01; [Fig. 2c](#F2){ref-type="fig"}), despite otherwise normal Ca~v~1.3 activation properties ([Supplementary Table 2](#SD1){ref-type="supplementary-material"}). This difference was not observed at P6-8 (p=0.59, [Fig. 2d](#F2){ref-type="fig"}), consistent with sparse synaptic localization of harmonin at this age ([Fig. 1g](#F1){ref-type="fig"}). Ca^2+^ microdomains, which primarily reflect presynaptic Ca^2+^ influx^[@R10]^, had higher amplitudes in mature *dfcr* than control IHCs (\~53%, p=0.02; [Fig. 2e, f](#F2){ref-type="fig"}). Taken together, these results show that harmonin directly inhibits synaptic Ca~v~1.3 channel density in IHCs, which is disrupted by the *dfcr* mutation.

Cell surface density of ion channels can be regulated by ubiquitination and targeting for proteosomal or lysosomal degradation^[@R11]^. Thus, we tested if harmonin enhanced ubiquitination of Ca~v~1.3 in HEK293T cells. Following immunoprecipitation with α~1~1.3 antibodies, western blotting revealed higher levels of ubiquitinated channels cotransfected with harmonin, which was intensified by the proteosomal inhibitor MG132 ([Fig. 3a,b](#F3){ref-type="fig"}). In addition, harmonin altered the distribution of cell-surface Ca~v~1.3 channels immunofluorescently labeled through an extracellular hemagglutinin epitope. While Ca~v~1.3 channels alone showed a fairly continuous distribution, harmonin caused Ca~v~1.3 channels to form large clusters in the plasma membrane ([Fig. 3c](#F3){ref-type="fig"}, [Supplementary Fig. 3](#SD1){ref-type="supplementary-material"}). The patchier cell-surface distribution of Ca~v~1.3 channels caused by harmonin was reversed by MG132 ([Fig. 3c](#F3){ref-type="fig"}). Given that MG132 broadly affects the ubiquitin system and may affect both proteosomal and lysosomal protein pathways, the altered distribution of Ca~v~1.3 channels caused by harmonin may result from improper trafficking and/or degradation of ubiquitinated channels. Although Ca~v~β subunits inhibit ubiquitination of Ca~v~ channels^[@R12],[@R13]^, the inhibition of Ca~v~1.3 current density by harmonin did not require Ca~v~β ([Fig. 3d](#F3){ref-type="fig"}) but was blocked by MG132 ([Fig. 3e](#F3){ref-type="fig"}; MG132 did not affect current density in cells with Ca~v~1.3 alone, [Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}). We conclude that harmonin tags Ca~v~1.3 channels for ubiquitination and alters their functional levels at the cell surface. This may constrain the number of available presynaptic Ca~v~1.3 channels in IHCs, a parameter that varies between IHC synapses^[@R10]^ and during development^[@R14]^. Together with evidence that harmonin regulates mechanotransduction currents^[@R8],[@R15]^, our findings reveal harmonin as not simply a scaffold, but an integral component of ion channel complexes and fundamental regulator of electrical and Ca^2+^ signaling in auditory hair cells.
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![Harmonin inhibits Ca~v~1.3 channels and is localized at inner hair cell synapses.\
(a) Myc-harmonin coimmunoprecipitates with FLAG-α~1~1.3 in cotransfected HEK293T cells (lane 1) but not in cells transfected with myc-harmonin alone (lane 2). (b) Western blot (upper panel) from pull-down assay shows GST-1.3CT (CT) but not GST (G) binds his-tagged PDZ2 of harmonin. Input (I) represents \~5% protein His-PDZ protein input. Ponceau staining (lower panel) shows amounts of GST-proteins used. Full length blots are presented in [Supplementary Fig.5](#SD1){ref-type="supplementary-material"}. (c) Harmonin inhibits Ca~v~1.3 I~Ba~ density in transfected HEK293T cells. Ca~v~1.3 alone, n=11; +harmonin, n=11. (d) Representative traces showing gating currents (I~gating~) of Ca~v~1.3 ± harmonin measured at the I~Ba~ reversal potential (+60 mV). (e) His-PDZ2 of harmonin binds to α~1~1.3 CT but not with L-A mutation. Pull-down assay was done as in *b*. (f) No effect of harmonin on I~Ba~ density for Ca~v~1.3 with L-A mutation (Ca~v~1.3~L-A~). Ca~v~1.3~L-A~ alone, n=8; Ca~v~1.3+harmonin, n=7. (*g*) Confocal projections of whole mounts of Organ of Corti from wild-type (WT, P7 or P15) or *Ca~v~1.3*^−/−^ mice (P7) double-labeled for CtBP2 (red) and Ca~v~1.3 (green) or harmonin (green*)*. Synaptic labeling of CtBP2 appears as spots basal to the nucleus, which is also labeled by these antibodies. Areas of colocalization (arrows) are yellow in the merged images. Scale bars, 10 μm. Graph shows distribution of harmonin-positive synapses in individual IHCs from P6--8 and P14--16 IHCs. In *c* and *f*, error bars represent s.e.m.](nihms-309524-f0001){#F1}

![*Dfcr* mutation prevents functional interaction of harmonin and Ca~v~1.3\
(a) Pull-down assays with GST or GST-α~1~1.3 CT and increasing amounts of lysates from HEK293T cells transfected with myc-harmonin or myc-*dfcr* harmonin, as indicated. Left 2 lanes show input (\~5%) and Ponceau staining (lower panel) shows GST or GST-α~1~1.3 CT used in the assay. Full length blots are presented in [Supplementary Fig.5](#SD1){ref-type="supplementary-material"}. (b) Same protocol as in [Fig.1c](#F1){ref-type="fig"} except in cells transfected with Ca~v~1.3 alone, n=7, +harmonin, n=9, or +*dfcr*-harmonin, n=8. (c,d) Plots of I~Ba~ density vs. test voltage from whole-cell patch clamp recordings at P16-18 (c) and P6-8 (d) from control (+/−; n=23 in *c*, n=45 in *d*) or *dfcr* (−/−; n=31 in *c*, n=42 in *d*) IHCs. (e,f) Simultaneous whole-cell patch clamp recordings and fluorescent measurement of presynaptic Ca^2+^ microdomains. (e) Representative hotspots of Fluo-5N fluorescence in control (+/+) and *dfcr* (−/−) IHCs during depolarization. Scale bar, 1 μm. (f) *Top*, Whole-cell I~Ca~ recorded in control (black line and dark grey area, n = 14) and *dfcr* (grey line and light grey area, n = 16) IHCs. *Bottom*, Background-subtracted and normalized Fluo-5N fluorescence change (ΔF/F~0~, mean±SD) in the center of the Ca^2+^ microdomain (41 domains in 14 control IHCs and 41 domains in 16 *dfcr* IHCs). In *b-d*, error bars represent s.e.m. Protocols for the use of mice were approved by the Institutional Animal Care and Use Committee at U. Iowa and U. Gottingen.](nihms-309524-f0002){#F2}

![Harmonin inhibits plasma membrane Ca~v~1.3 channel density through a ubiquitin-dependent pathway\
(a,b) Ubiquitination of Ca~v~1.3 channels in HEK293T cells transfected with Ca~v~1.3±harmonin. Ca~v~1.3 channels were immunoprecipitated with α~1~1.3 antibodies and western blotting was performed with anti-ubiquitin (Ub, top panel) or α~1~1.3 antibodies (bottom panel). Cells were maintained with (+) or without (−) MG132 (5 μM, 12 h) prior to lysis. Ubiquitination of Ca~v~1.3 was quantitated and plotted as relative intensities (b); \*, p\<0.05. Full length blots are presented in [Supplementary Fig.5](#SD1){ref-type="supplementary-material"}. (c) Confocal micrographs showing immunofluorescence of cell-surface labeled HA-Ca~v~1.3 channels transfected alone or with harmonin. Pretreatment with MG132 was as in (a). Scale bars, 5 μm. (d,e) I~Ba~ density recorded as in [Fig.1c](#F1){ref-type="fig"} in HEK293T cells cotransfected without Ca~v~β (d; n=12 for Ca~v~1.3, n=11 for +harmonin) or with Ca~v~β (e; n=12 for Ca~v~1.3 alone, n=14 for +harmonin, n=11 for +harmonin+MG132). In (e), cells were treated with MG132 (5 μM) 1-3 h before recording. In *b, d, e*, error bars represent s.e.m.](nihms-309524-f0003){#F3}
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